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Abstract  
Introduction: Tumors of salivary glands are rare. According to Johns and Goldsmith in 1989, their annual incidence is less than 1/100000 without 
noteworthy geographical gap. But other authors suggest that their distribution may vary according to the race and geographical location.In 
Cameroon, existing studies give incomplete data. Hence, we underwent this study in order to draw the general profile of salivary gland tumors in 
Cameroon. Methods: A retrospective study was carried out on the period spanning from January 2000 to December 2010 (11 years). It was done 
in nine Pathology services of different hospitals in Yaoundé, Douala and Bamenda. We consulted the archive registers of those services, retaining 
any patient with salivary gland tumor, whatever the histological type or location. Information gathered was the year of diagnosis, the service, the 
age and sex, the site of the tumor (gland) the histological type and the benign/ malignant character. Results: We recruited a total of 275 files. 
Women were 56% (154/275) and men 44% (121/275) of the sample. Fifty eight tumors were malignant (21.9%) while 217 were benign (78.1%). 
The overall mean age was 37.44 years, with extremes between 1 and 84 years. Pleomorphic adenoma (60.36%) was the most common benign 
tumor. Adenoid cystic carcinoma (31%), mucoepidermoid carcinoma (22.4%) and adenocarcinoma (19%) were the most common malignant 
tumors. Palate (66.7%), cheek (30%) and lips (3.3%) were the sites were the minor salivary glands were mostly involved. Conclusion: The 
differences with western world authors suggest a geographical variability of salivary gland tumors. 
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Introduction 
 
The tumors of salivary glands are rare [1-3]. According to Johns and 
Goldsmith in 1989, their annual incidence is less than 1/100000 
inhabitants, without noticeable geographical gap andthey represent 
less than 5 % of head and neck tumors [1]. It is postulated in the 
western world literature that their distribution is about 100 :10 :10 
:1 for parotid gland, sub maxillary gland, accessory salivary glands 
and sublingual gland respectively [2]. But recent African studies 
found a distribution of 1 :1 :1 for parotid, sub maxillary and 
accessory salivary glands respectively [3]. In Cameroon, existing 
data are partial because they are gland specific or on limited study 
samples.We therefore undertook this study in order to study the 
main histopathological and epidemiological features of the tumors of 





We carried out a retrospective, descriptive and multicentric study on 
the 11-year period spanning from January 2000 to December 2010. 
The protocole of the study received the approval of the Ethics 
Committee of the Faculty of Medicine and Biomedical Sciences of 
the University of Yaoundé I. It was conducted in nine Pathology 
services of Yaoundé, Douala and Bamenda. We chose those centers 
because together they process almost all the pathological samples 
of the country, so as to have the most representative national scale 
picture possible. The centers based in Yaoundé were the Yaoundé 
Gyneco-Obstetric and Pediatric Hospital, the Association 
Pathologieetdéveloppement, the CentrePasteur du Cameroun, the 
University Hospital Center, the Yaoundé Central Hospital and the 
Yaoundé General Hospital. In Douala were involved the Laquintinie 
Hospital and the General Hospital. In Bamenda the Mezam Polyclinic 
was selected. We used the patients’ records of these services, 
recruiting the file of any patient with a salivary gland tumor, either 
from principal or accessory salivary gland,benign or malignant. The 
data collected were the year of diagnosis, the service, the age, the 
sex, the location of the tumor (gland) and the histological type. All 
the pathologists from these centers had prepared their slides with 
the Hematein-Eosin stain. The tumors were classified using the 
WHO classification of 2005 [4]. Data were collected on fore-
established sheets and the analysis was done with the softwares 




We recruited a total of 275 files from the nine hospital centers. 
Females were 154 (56%) and males 121 (44%) of the sample. 
There was an increase of the number of cases per year as from 
2007, with a peak in 2009 being 45 cases. The distribution of cases 
per center was as follows: Mezam Polyclinic (63), Centre Pasteur du 
Cameroun(58), Douala General Hospital (39), Yaoundé University 
Hospital Center (33), Association PathologieetDéveloppement(29), 
Yaoundé General Hospital (19), Douala Laquintinie Hospital (15), 
Yaoundé central Hospital (12) and Yaoundé Gyneco-Obstetric and 
Pediatric Hospital (7). The detail of the contribution of each 
pathology center is given in Table 1. Fifty eight tumors were 
malignant (21.1%) while 217 were benign (78.9%). The mean age 
of the patients was 37.44 (SD: 54.7) years with extremes of 1 and 
84 years.Mean age was 46.9 (SD: 43.13) years with extremes of 18 
and 79 years in the patients with malignant tumors versus 34.9 (SD: 
39.6) years with extremes of 1 and 84 years in those with benignant 
tumors (p=0.03). The distribution of tumors according to age range 
and histology is given in Figure 1. We obtained the sequence of 
135:109:30 for parotid, submandibular and accessory salivary 
glands respectively, thus giving a parotid/submandibular gland ratio 
of 1.23 (Table 2). Pleomorphic adenoma (60.36% of benign tumors 
and 47.7% of all tumors) was the most frequent benign tumor. The 
cystic adenoid carcinoma was the most frequent malignant tumor 
(31%of them), followed by the mucoepidermoid carcinoma 
(22.4%), and adenocarcinoma (19%). There were 30 cases (20%) 
of accessory salivary gland involvement, of which 20% were 
malignant tumors. The palate (66.7%), the cheek (30%) and the 
lips (3.3%) were the sites affected by accessory salivary gland 
tumors. There were 54 inflammatory pseudo tumors, representing 
24.8% of benign tumors and 19.6% of the sample (Table 3). We 
compared our results to those of other authors. It shows a similarity 






There is a boom of tumoral diseases in Africa in general and 
Cameroon in particular. It is estimated that 12,000 to 14,000 new 
cases are diagnosed each year in the Country [5, 6]. Tumours of 
head and neck follow the same progression. In this retrospective 
work on the tumors of salivary glands, we found a predominance of 
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benign tumors (78.1%), pleiomorphic adenoma being the most 
frequent tumor and cystic adenoid carcinoma the most frequent 
malignant tumor. The parotid/submaxillary ratio of 1.23, far less 
than the 8 to 10 of western world literature. Accessory salivary 
gland involvement represented 20% of cases, of which 20% were 
malignant. 
  
There was a raise of the number of tumors per year between 2000 
and 2007. This was also noticed by Bahiru in Ethiopia [7]. It is due 
to a better access to pathology diagnosis thanks to the creation of 
new laboratories on one hand and to a better sensitization of the 
health personnel on cancer and the importance of pathological 
diagnosis on the other hand. The fact that Polyclinic Mezam alone 
has up to 22.9% of cases is because this center is almost the only 
situated in a highly populated zone and thus receives patients from 
3 regions (North-West, West and Littoral). In the big cities Yaoundé 
and Douala, a greater number oflaboratories allows a sharing of 
patients. The parotid/submandibular ratio obtained (1.23) is near to 
those found by other African authors [2], but far from the one 
found in most of western world studies (8 to 10) [8]. This supports 
the fact that the distribution of those tumors is not uniform and 
varies greatly depending ongeographical localization. Besides, the 
parotid as the most involved site is a universal finding in the 
literature [8-11]. 
  
The mean age of patients was 37.4 years, similar to what Kayembe 
(37.4) [10] and Vuhahula (38.4) [2] found in Ouganda and Congo 
respectively. It was higher than the 30 years found by Bahiru [7], 
what he explained by the fact that in those regions persons of the 
third age are more attracted to alternative medicines. The age 
range most affected by malignant salivary gland tumors was the 60 
and above (24.1%). Evesonet al found a peak of malignant tumors 
at 70 years [9]. The 20-30 age range was the most affected by 
benign tumors (27.2%). It is younger compared to the findings of 
Eveson [9] and Onyango [11] who found peaks of incidence at 60 
and 40-59 years respectively. These differences suggest a variation 
of the distribution of those tumors according to the site, due to 
different influencing factors. Especially, the longer life expectancy, 
the development of means of prevention and the better quality of 
life in the western world [12]. 
  
Women were predominant in the sample, with a male/female sex 
ratio of 0.78. Kayembein Congo and Vuhahula in Ouganda found 
similar results with 0.8 and 0.76 respectively [2, 10].This 
predominance can be due to the women’s tendency to better care 
about their cosmetic appearance, thus seeking more often medical 
help when a tumor deformity appears.Malignant tumors also 
predominate in the women (51.7%). It was also found by Vuhahula 
(52.4%), unlike Ben Brahimand El-Gazayerliwho instead found the 
predominance in males [8, 13]. 
  
There was a predominance of benign tumors (78.1%). This was 
similar to the results of Ben Brahim [13] and Ouoba [14] with 
respectively 88.3% and 83.3% of benign tumors. Vuhahula [2] and 
Masanja [15] found an almost equal distribution : 54% of benign 
tumors and 46 % of malignant tumors. This is due to the fact that 
in our study, the regions concerned have a good health coverage 
and the health personnel performs surgery straightaway in front of 
a clinical suspicion of benign tumor, surgery easily accepted by the 
patients in this context, contrary to when malignancy is suspected, 
then preferring traditional medicine. The benign tumors could also 
have been over diagnosed in our sample since some of the 
pathological characteristics of pleomorphic adenomas are similar to 
those of carcinomas. So, some pathologists here as elsewhere 
classify low grade malignant tumors in the benign tumors [4, 16]. In 
addition to that, immunohistochemical methods of pathology 
diagnosis are not yet used in the study centers. 
  
Proportionally in this study, the parotid gland is less often the site of 
tumor (49%) than in the western studies (70%) [16], while the 
submandibular gland is more often, with 39% versus 10-15% [1]. 
This has been found by other African authors [2, 14]. Some like 
Aboul Nasr (1961) emitted the hypothesis that endemic parotiditis 
could decrease the susceptibility of parotid gland and increase that 
of the submandibular gland to neoplasms [8]. El-Gazayerli et al. also 
noticed that malnutrition altered more the serous cells than the 
mucous, thus decreasing the susceptibility of parotid gland to 
neoplasms [8]. 
  
Pleomorphic adenoma represented 47.7% of the tumors of salivary 
glands, being the first. This is constant finding for all the authors. 
Masanja and Vuhahula found similar proportions of 44.4% and 
40.9% respectively [2, 15], contrary to Ben Brahim (61.7%) [13] 
and Bahiru (58.5%) [7]. The cystic adenoid carcinoma was the most 
frequent malignant (6.6%), followed by the mucoepidermoid 
carcinoma (4.7%). Vuhahulain Ouganda, Kayembe in Congo and 
Masanja in Tanzania also found cystic the same occurrence 13.4%, 
15.9% and 24.8% respectively. But Ben Brahim, Bahiru Speight et 
Ochicha [17] found the mucoepidermoid carcinoma as the most 
frequent malignant tumor (3.9%, 10.8%, 10% and 5.12% 
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respectively) ahead of cystic adenoid carcinoma (2.2%, 10.2 % ,4% 
and1.28%). Cystadenolymphoma (Whartin’s tumor) represented 
0.7% of the sample. Its rarity is constant in African series [3, 10], 
while in western countries it accounts for 5 to 20% of all tumors of 
salivary glands [2]. The young age of African patients has been 
advanced to explain the gap [8]. But this argument is not sufficient 
since the age range of their peak in African series contains the 
meanage of Western World series [2]. 
  
Twenty two per cent of the tumors of accessory salivary glands 
were malignant.Ben Brahim found a lower proportion of malignancy, 
9.1%, contrary to western literature which reports as much as 50% 
of tumors of those glands being malignant [16]. We have no 
explanation to this difference. The limits of this studiy are its 
inability to clearly discriminate the factors influencing the 
distribution of salivary gland tumors, since we didn’t have sufficient 





This study shows a distribution of salivary gland tumors different 
from that of western countries and aligning with other African 
authors, strengthening the hypothesis that salivary gland tumor 
present with regional variations which could be related to endemic 
infections and nutritional factors amongst other things. But 
prospective studies need to be carried out on bigger samples in 
order to better discriminate the influencing factors. 
  
What is known about this topic 
 
 Salivary gland tumors are rare. 
 The parotid/submandibular ration equals 8 to 10. 
 80% of the tumors arise from the parotids. 
 
What this study adds 
 
 Parotid/submandibular ratio is 1.23. 
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Table 1: Contribution of each pathology service per year 
  YCH UHC YGH YGOPH CPC DGH DLH APD MP 
2000 1 0 0 0 2 1 0 0 1 
2001 0 2 2 1 5 6 2 2 3 
2002 2 2 1 0 1 1 0 1 2 
2003 1 2 2 0 4 5 2 2 2 
2004 2 3 1 1 3 1 2 1 1 
2005 1 3 4 0 7 4 1 2 2 
2006 1 2 2 1 5 4 1 3 4 
2007 2 5 2 0 11 5 2 3 11 
2008 1 2 1 1 6 3 2 3 11 
2009 1 5 3 2 6 5 2 7 12 
2010 0 7 1 1 6 4 1 5 13 
Total 12 33 19 7 58 39 15 29 63 
YCH: Yaounde Central Hospital, UHC: UniversityHospital Center, YGH: Yaounde General Hospital, CPC: Centre Pasteur 
du Cameroun, DGH: Douala General Hospital, DLH: DoulaLaquinitineHospital, APD: Association Pathologie et 
Développement, MP: MezamPolyclinic. 
 
 
Table 2: Distribution of tumors according to the site 
  Distribution of tumors according to site   
MALIGNANT  CAC MEC AdenoK Lymphoma Others Total 
Parotid 10 8 7 0 10 35 
Submandibular 4 5 2 2 4 17 
Accessory 4 0 2 0 0 6 
Sublingual 0 0 0 0 0 0 
Total 18 13 11 2 14 58 
BENIGN   Pl. adenoma Whartin’s Lymphangioma Others Total 
Parotid 63 0 0 37 100 
Submandibular 47 2 1 42 92 
Accessory 22 0 0 2 24 
Sublingual 0 0 0 1 1 
Total 132 2 1 82 217 
Predominant sites were parotid and submandibular glands. 
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Table 3: Distribution of the tumors referred to as « others » 



















This group was dominated by benign tumours. 
The inflammatory pseudo tumor represented 55.67% of them. 
 
 














275 78 268 78 - 
Benigntumors 78.1% 56.4% 54% 85.9%   
Malignanttumors 21.9% 43.6% 46% 14.1%   
  


















Female Female Female Male Female 
Meanage 37. 4 yrs 36.5yrs 38.1 yrs 36.3yrs - 
Peak incidence Benign 20-30 yrs 21-30 43,1 yrs 31-40 yrs - 
Malignant 60 yrs& + 60 yrs& + 33.5 yrs 40 yrs - 
Cystadenilymphoma 0.7% 0 0 10.25% - 
Parotid/submandibular ratio 1.23 1.9 1.15 3 8 to 10 
* : Cysticadenoidcarcinoma** : Mucoepidermoidcarcinoma. Pl.=Pleomorphic. 
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Figure 1: Distribution of patients according to age range and histology; the red line represents the slope of the 
frequency of malignant tumors 
 
